117 related articles for article (PubMed ID: 7624149)
1. Frequent deletion of chromosome 19 and a rare rearrangement of 19p13.3 involving the insulin receptor gene in human ovarian cancer.
Amfo K; Neyns B; Teugels E; Lissens W; Bourgain C; De Sutter P; Vandamme B; Vamos E; De Grève J
Oncogene; 1995 Jul; 11(2):351-8. PubMed ID: 7624149
[TBL] [Abstract][Full Text] [Related]
2. Molecular genetic changes associated with ovarian cancer.
Weitzel JN; Patel J; Smith DM; Goodman A; Safaii H; Ball HG
Gynecol Oncol; 1994 Nov; 55(2):245-52. PubMed ID: 7959292
[TBL] [Abstract][Full Text] [Related]
3. Frequent loss of heterozygosity on chromosomes 6q, 11, and 17 in human ovarian carcinomas.
Lee JH; Kavanagh JJ; Wildrick DM; Wharton JT; Blick M
Cancer Res; 1990 May; 50(9):2724-8. PubMed ID: 2328498
[TBL] [Abstract][Full Text] [Related]
4. Deletion of chromosome 11p13-11p15.5 sequences in invasive human ovarian cancer is a subclonal progression factor.
Vandamme B; Lissens W; Amfo K; De Sutter P; Bourgain C; Vamos E; De Grève J
Cancer Res; 1992 Dec; 52(23):6646-52. PubMed ID: 1423308
[TBL] [Abstract][Full Text] [Related]
5. Human epithelial ovarian cancer allelotype.
Cliby W; Ritland S; Hartmann L; Dodson M; Halling KC; Keeney G; Podratz KC; Jenkins RB
Cancer Res; 1993 May; 53(10 Suppl):2393-8. PubMed ID: 8485726
[TBL] [Abstract][Full Text] [Related]
6. Allelotype of human ovarian cancer.
Sato T; Saito H; Morita R; Koi S; Lee JH; Nakamura Y
Cancer Res; 1991 Oct; 51(19):5118-22. PubMed ID: 1655245
[TBL] [Abstract][Full Text] [Related]
7. Recurrent cytogenetic aberrations and loss of constitutional heterozygosity in ovarian carcinomas.
Kiechle-Schwarz M; Bauknecht T; Karck U; Kommoss F; du Bois A; Pfleiderer A
Gynecol Oncol; 1994 Nov; 55(2):198-205. PubMed ID: 7959284
[TBL] [Abstract][Full Text] [Related]
8. Frequent loss of heterozygosity on chromosome 18 in ovarian adenocarcinoma which does not always include the DCC locus.
Chenevix-Trench G; Leary J; Kerr J; Michel J; Kefford R; Hurst T; Parsons PG; Friedlander M; Khoo SK
Oncogene; 1992 Jun; 7(6):1059-65. PubMed ID: 1594239
[TBL] [Abstract][Full Text] [Related]
9. Reverse painting of microdissected chromosome 19 markers in ovarian carcinoma identifies a complex rearrangement map.
Micci F; Weimer J; Haugom L; Skotheim RI; Grunewald R; Abeler VM; Silins I; Lothe RA; Trope CG; Arnold N; Heim S
Genes Chromosomes Cancer; 2009 Feb; 48(2):184-93. PubMed ID: 18973136
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN
Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity at selective sites on chromosomes 13 and 17 in human breast carcinoma.
Thorlacius S; Jonasdottir O; Eyfjord JE
Anticancer Res; 1991; 11(4):1501-7. PubMed ID: 1746906
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity in human ovarian cancer on chromosome 19q.
Bicher A; Ault K; Kimmelman A; Gershenson D; Reed E; Liang B
Gynecol Oncol; 1997 Jul; 66(1):36-40. PubMed ID: 9234918
[TBL] [Abstract][Full Text] [Related]
13. A commonly deleted region in ovarian cancer on chromosome 19p13.3, not including the OAZ1 gene.
Yanaihara N; Okamoto A; Matsufuji S
Int J Oncol; 2003 Sep; 23(3):567-75. PubMed ID: 12888889
[TBL] [Abstract][Full Text] [Related]
14. Allelic loss on chromosome 7q in ovarian adenocarcinomas: two critical regions and a rearrangement of the PLANH1 locus.
Kerr J; Leary JA; Hurst T; Shih YC; Antalis TM; Friedlander M; Crawford E; Khoo SK; Ward B; Chenevix-Trench G
Oncogene; 1996 Oct; 13(8):1815-8. PubMed ID: 8895529
[TBL] [Abstract][Full Text] [Related]
15. Recurrent cytogenetic aberrations in human ovarian carcinomas.
Kiechle-Schwarz M; Bauknecht T; Schmidt J; Walz L; Pfleiderer A
Cancer Detect Prev; 1995; 19(3):234-43. PubMed ID: 7750111
[TBL] [Abstract][Full Text] [Related]
16. A novel 4-cM minimally deleted region on chromosome 11p15.1 associated with high grade nonmucinous epithelial ovarian carcinomas.
Lu KH; Weitzel JN; Kodali S; Welch WR; Berkowitz RS; Mok SC
Cancer Res; 1997 Feb; 57(3):387-90. PubMed ID: 9012461
[TBL] [Abstract][Full Text] [Related]
17. Homozygous deletion on chromosome 9p and loss of heterozygosity on 9q, 6p, and 6q in primary human small cell lung cancer.
Merlo A; Gabrielson E; Mabry M; Vollmer R; Baylin SB; Sidransky D
Cancer Res; 1994 May; 54(9):2322-6. PubMed ID: 8162574
[TBL] [Abstract][Full Text] [Related]
18. Frequent loss of heterozygosity and three critical regions on the short arm of chromosome 8 in ovarian adenocarcinomas.
Wright K; Wilson PJ; Kerr J; Do K; Hurst T; Khoo SK; Ward B; Chenevix-Trench G
Oncogene; 1998 Sep; 17(9):1185-8. PubMed ID: 9764830
[TBL] [Abstract][Full Text] [Related]
19. Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2.
Schultz DC; Vanderveer L; Buetow KH; Boente MP; Ozols RF; Hamilton TC; Godwin AK
Cancer Res; 1995 May; 55(10):2150-7. PubMed ID: 7743516
[TBL] [Abstract][Full Text] [Related]
20. Deletion mapping of two potential chromosome 14 tumor suppressor gene loci in ovarian carcinoma.
Bandera CA; Takahashi H; Behbakht K; Liu PC; LiVolsi VA; Benjamin I; Morgan MA; King SA; Rubin SC; Boyd J
Cancer Res; 1997 Feb; 57(3):513-5. PubMed ID: 9012483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
